Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months
ABSTRACT: Objectives: To evaluate the safety, immunogenicity, and lot-to-lot consistency of Sabin strain-based inactivated polio vaccine (sIPV) in a five-dose vial presentation. Methods: Stage I was an open-label safety observation, in which 72 healthy subjects (including 24 adults, children, and i...
Main Authors: | Guangwei Feng, Deyu Jiang, Weixiao Han, Zhiqiang Xie, Zhiwei Jiang, Lili Huang, Jianfeng Wang, Wei Zhang, Li Xu, Jiebing Tan, Wangyang You, Guoliang Cui, Changgui Li, Yanxia Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971223000206 |
Similar Items
-
Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial
by: Yan Zheng, et al.
Published: (2022-02-01) -
Immune Persistence following Primary Immunization and the Immunogenicity and Safety of a Booster Dose of a Multidose Sabin Strain-Based Inactivated Polio Vaccine in Infants Aged 18 Months
by: Guangwei Feng, et al.
Published: (2024-01-01) -
Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial
by: Dandan Zhu, et al.
Published: (2022-11-01) -
Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II
by: Anastasia Piniaeva, et al.
Published: (2021-05-01) -
A phase Ⅱ, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine
by: Rong Tang, et al.
Published: (2020-11-01)